Lung Cancer Treatment

Lung cancer therapy focuses on the management of malignant cells in the respiratory system, specifically targeting common Indian mutations like ALK and EGFR. Dr. Vipul Doshi applies real-world clinical data and post-osimertinib failure strategies to ensure patients receive the most effective systemic therapy. Specialized care to improve survival rates and maintain respiratory function through advanced medical oncology.

• ALK-Positive Care
  Targeted management for Anaplastic Lymphoma Kinase (ALK)-positive lung cancer cases.

• EGFR Mutation Therapy
  Specialized treatment protocols for Epidermal Growth Factor Receptor (EGFR)–mutated NSCLC.

• TKI Therapy
  Utilizing Tyrosine Kinase Inhibitors to block specific growth signals in lung tumors.

• Combination Regimens
  Integrating chemotherapy with targeted agents for superior disease control.

• Outcome Monitoring
  Tracking clinical profiles to adjust therapy based on the latest Indian research data.